Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI
Review

Resveratrol and neuroprotection: modulation of cellular dynamics and signaling networks in neurodegenerative diseases

Md Abul Hassan Md. Al Amin Sherouk Hussein Sweilam Mohammad Abohassan Karthickeyan Krishnan Jeetendra Kumar Gupta Patibandla Jahnavi Rajeshwar Vodeti R. Radha Prem Shankar Gupta Konatham Teja Kumar Reddy
Jul 2026 · InflammoPharmacology · Vol 34, pp. 5093 - 5117 · 1 citation · 162 references
Medicine

TL;DR

This review demonstrates the regulatory effects of resveratrol on cellular signaling pathways linked to NDs and its neuroprotective mechanisms and critically compare evidence from preclinical and clinical studies, demonstrating both therapeutic potential and translational limitations.

DOI PubMed Semantic Scholar
View source

Similar papers

Aug 2026

Astragalin confers coordinated neuroprotection in Parkinson's disease models through modulation of neurotrophic, anti-inflammatory, and synuclein-related pathways.

The natural flavonoid Astragalin concurrently addresses three core pathological processes in PD, namely dopaminergic neuron degeneration, α-synucleinopathy, and neuroinflammation, through coordinated modulation of interconnected molecular pathways.

Jun Wang, Jie-Yu He, Qin Huang et al. · 0 citations
Aug 2026

Neuroprotective Potential of Terpenoids: A Promising Avenue in Neurology.

Terpenoids have the potential to be developed as novel multitarget neurotherapeutic agents with further research to bridge preclinical promise and clinical validation, and structural optimisation and advanced delivery systems, such as nanoparticles, cyclodextrin inclusion, combined therapeutic strategies, precision-tar...

Nidhi Gairola, Sushmita Uniyal, Jaya Martolia et al. · 0 citations
Review Open access Sep 2026

SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential

The structural and catalytic features of SIRT1 are summarized, the mechanisms linking SIRT1 to cognitive impairment across major neurodegenerative diseases are examined, and the opportunities and limitations of SIRT1‐targeted therapeutic strategies are evaluated.

Jia-Bin Duan, Jia-Qiang Liu, Qing-Sheng Meng et al. · 0 citations
Review Open access Aug 2026

Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer’s disease

Overall, natural products represent promising candidates for managing neurogenesis and neuroplasticity in AD, although further clinical studies are required to validate their therapeutic efficacy.

A. Shaheen, Mou-Sa A. Mai, Merhan O. Hindam et al. · 2 citations
Review Open access Aug 2026

Targeting Neurodegeneration With Naringenin: Mechanistic Perspectives and Therapeutic Implications

NAR has demonstrated the ability to reduce amyloid-β plaque deposition, inhibit α-synuclein aggregation, preserve dopaminergic neurons, modulate immune responses in multiple sclerosis, and improve functional recovery after spinal cord injury.

Nista Gurung, Ganesh Bohara, Nikesh Rimal et al. · 0 citations
Review Open access Jul 2026

NEUROPROTECTIVE SECONDARY METABOLITES: MECHANISMS AND THERAPEUTIC POTENTIAL IN NEURODEGENERATIVE DISEASES

This review comprehensively examines the neuropharmacology of key secondary metabolites, including huperzine A, curcumin, resveratrol, epigallocatechin gallate (EGCG), and ginsenosides, focusing on their mechanisms against neurodegeneration, and critically evaluates evidence for neuroprotection through acetylcholineste...

Moses Okpata Chukwuebuka · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.